These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31204978)

  • 1. Measles: A dangerous vaccine-preventable disease returns.
    Porter A; Goldfarb J
    Cleve Clin J Med; 2019 Jun; 86(6):393-398. PubMed ID: 31204978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The return of measles--an unnecessary sequel.
    Mandell BF
    Cleve Clin J Med; 2019 Jun; 86(6):365-366. PubMed ID: 31204975
    [No Abstract]   [Full Text] [Related]  

  • 3. Measles outbreaks in Italy: A paradigm of the re-emergence of vaccine-preventable diseases in developed countries.
    Siani A
    Prev Med; 2019 Apr; 121():99-104. PubMed ID: 30763627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles resurgence in the USA: how international travel compounds vaccine resistance.
    Sarkar S; Zlojutro A; Khan K; Gardner L
    Lancet Infect Dis; 2019 Jul; 19(7):684-686. PubMed ID: 31079949
    [No Abstract]   [Full Text] [Related]  

  • 5. Measles outbreaks: who are at risk and why.
    Grimes DE; Woolbert LF
    J Pediatr Health Care; 1989; 3(4):187-93. PubMed ID: 2547055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resurgence of measles in the United States: how did we get here?
    Feemster KA; Szipszky C
    Curr Opin Pediatr; 2020 Feb; 32(1):139-144. PubMed ID: 31790030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of measles vaccine during the 1990 measles epidemic.
    King GE; Markowitz LE; Patriarca PA; Dales LG
    Pediatr Infect Dis J; 1991 Dec; 10(12):883-8. PubMed ID: 1766702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Talk to Patients About: Measles.
    Price S
    Tex Med; 2018 Apr; 114(4):43. PubMed ID: 30716155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Legal and Policy Responses to Vaccine-Preventable Disease Outbreaks.
    Barraza L; Reiss D; Freeman P
    J Law Med Ethics; 2019 Jun; 47(2_suppl):11-14. PubMed ID: 31298132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australia: an island in a sea of measles.
    Williamson KM; Merritt T; Durrheim DN
    Med J Aust; 2020 Aug; 213(3):101-103.e1. PubMed ID: 32535928
    [No Abstract]   [Full Text] [Related]  

  • 11. Celebrating the ACP Centennial: From the Annals Archive-Measles and Vaccination.
    Cotton D
    Ann Intern Med; 2015 May; 162(9):657. PubMed ID: 25938995
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of vaccine exemptions in the resurgence of measles.
    Nimblett-Clarke A
    JAAPA; 2021 Feb; 34(2):36-40. PubMed ID: 33470720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Talk to Patients About: Cleanliness vs. Vaccines.
    Price S
    Tex Med; 2020 Apr; 116(4):47. PubMed ID: 32353155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendation for the monitoring of measles eradication in the American region.
    Epidemiol Bull; 2003 Sep; 24(3):6-10. PubMed ID: 15112628
    [No Abstract]   [Full Text] [Related]  

  • 15. Problems in the eradication of measles.
    Riley HD
    South Med J; 1976 Sep; 69(9):1113-5. PubMed ID: 968521
    [No Abstract]   [Full Text] [Related]  

  • 16. Measles still spreads in Europe: who is responsible for the failure to vaccinate?
    Lopalco PL; Martin R
    Euro Surveill; 2010 Apr; 15(17):. PubMed ID: 20460089
    [No Abstract]   [Full Text] [Related]  

  • 17. Measles outbreaks are still here to stay.
    Leung KKY; Hon KL
    Hong Kong Med J; 2020 Dec; 26(6):551. PubMed ID: 33350975
    [No Abstract]   [Full Text] [Related]  

  • 18. Mass use of live measles vaccine in aboriginal children in the Northern Territory.
    Langsford WA; Vawser ND
    Med J Aust; 1969 Feb; 1(5):223-5. PubMed ID: 5777901
    [No Abstract]   [Full Text] [Related]  

  • 19. Measles and human movement in Europe.
    Massad E
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30312454
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of COVID-19 on the laboratory turn-around time of vaccine-preventable disease surveillance: the case of measles in South Sudan.
    Kunjok DM; Zingbondo IM
    Pan Afr Med J; 2020; 37():245. PubMed ID: 33552363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.